deficit de hierro

¿Es usted
profesional sanitario?

No

Está usted accediendo a la página web “Déficit de Hierro”, dirigida a difundir información médica y promover la formación sobre los estados carenciales de hierro y la anemia ferropénica.

La información contenida en esta página está destinada exclusivamente a profesionales sanitarios con capacidad para prescribir o dispensar medicamentos, por lo que se requiere una formación especializada para su correcta interpretación. Si Vd. no es profesional sanitario cualificado, Zambon no se hace responsable de los perjuicios que pueda sufrir por las decisiones basadas en el contenido de esta página o de cualquiera de sus enlaces.

+

Selección bibliográfica de artículos


Semestralmente se realiza una actualización de la revisión bibliográfica según los criterios establecidos.

La selección actual de artículos corresponde a material publicado desde enero de 2013 hasta febrero de 2017.

Los usuarios pueden solicitar a la Secretaría Científica el envío vía e-mail de aquellos artículos que sean de su interés.


Oncología

  • Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.
    Park S, Jung CW, Kim K, Kim SJ, Kim WS, Jang JH.
    Oncotarget. 2015 Oct 26. doi: 10.18632/oncotarget.5658.

  • Iron metabolism and iron supplementation in cancer patients.
    Ludwig H, Evstatiev R, Kornek G, Aapro M, Bauernhofer T, Buxhofer-Ausch V, Fridrik M, Geissler D, Geissler K, Gisslinger H, Koller E, Kopetzky G, Lang A, Rumpold H, Steurer M, Kamali H, Link H.
    Wien Klin Wochenschr. 2015 Sep 15. [Epub ahead of print]

  • Adenocarcinoma of the third and fourth portions of the duodenum: The capsule endoscopy value.
    Paquissi FC, Lima AH, Lopes Mde F, Diaz FV.
    World J Gastroenterol. 2015 Aug 21;21(31):9437-41. doi: 10.3748/wjg.v21.i31.9437.

  • BRAF V600E mutation in colorectal cancer is associated with right-sided tumours and iron deficiency anaemia.
    Sideris M, Adams K, Moorhead J, Diaz-Cano S, Bjarnason I, Papagrigoriadis S.
    Anticancer Res. 2015 Apr;35(4):2345-50.

  • Risk of Cancer in Patients with Iron Deficiency Anemia: A Nationwide Population-Based Study.
    Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, Kuan AS, Chen SC, Chen TJ, Liu CJ.
    PLoS One. 2015 Mar 17;10(3):e0119647. doi: 10.1371/journal.pone.0119647.

  • Management of iron deficiency anemia: A survey of pediatric hematology/oncology specialists.
    Powers JM, McCavit TL, Buchanan GR.
    Pediatr Blood Cancer. 2015 Feb 7. doi: 10.1002/pbc.25433. [Epub ahead of print]

  • Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.
    Hedenus M, Karlsson T, Ludwig H, Rzychon B, Felder M, Roubert B, Birgegård G.
    Med Oncol. 2014 Dec;31(12):302. doi: 10.1007/s12032-014-0302-3. Epub 2014 Nov 6.

  • Impact of preoperative anemia on relapse and survival in breast cancer patients.
    Zhang Y, Chen Y, Chen D, Jiang Y, Huang W, Ouyang H, Xing W, Zeng M, Xie X, Zeng W.
    BMC Cancer. 2014 Nov 18;14:844. doi: 10.1186/1471-2407-14-844.

  • Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer.
    Peerschke EI, Pessin MS, Maslak P.
    Am J Clin Pathol. 2014 Oct;142(4):506-12. doi: 10.1309/AJCPCVZ5B0BOYJGN.

  • Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
    Shu T, et al.
    Eur J Haematol, 2014; Jun.

  • The yield of colorectal cancer among fast track patients with normocytic and microcytic anaemia.
    Panagiotopoulou IG, Fitzrol D, Parker RA, Kuzhively J, Luscombe N, Wells AD, Menon M, Bajwa FM, Watson MA.
    Ann R Coll Surg Engl. 2014 May;96(4):289-93. doi: 10.1308/003588414X13814021680076.

  • Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument.
    Mäenpää J, Puistola U, Riska H, Sintonen H, Saarni O, Juvonen E, Kellokumpu-Lehtinen PL.
    Anticancer Res. 2014 May;34(5):2325-9.

  • Iron homeostasis in breast cancer.
    Marques O, da Silva BM, Porto G, Lopes C.
    Cancer Lett. 2014 May 28;347(1):1-14. doi: 10.1016/j.canlet.2014.01.029. Epub 2014 Jan 31.

  • Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
    Murphy M, Close J, Lottenberg R, Rajasekhar A.
    Am J Med Sci. 2014 Mar;347(3):254-5. doi: 10.1097/MAJ.0000000000000228.

  • Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
    Akin M, et al.
    Pediatr Hematol Oncol. 2014 Feb;31(1):57-61.

  • U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.
    Tefferi A, Finke CM, Lasho TL, Wassie EA, Knudson R, Ketterling RP, Hanson CA, Pardanani A.
    Leukemia. 2014 Feb;28(2):431-3. doi: 10.1038/leu.2013.286. Epub 2013 Oct 7.

  • Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F, Yu WJ, Wang XH, Tang YT, Guo L, Jiao XY.
    Clin Chim Acta. 2014 Jan 20;428:14-9. doi: 10.1016/j.cca.2013.10.015.

  • Roles of the hepcidin-ferroportin axis and iron in cancer.
    Wu XN, Su D, Wang L, Yu FL.
    Eur J Cancer Prev. 2014 Jan 6.

  • Ferrous Sulfate (Fe2+) Had a Faster Effect Than Did Ferric Polymaltose (Fe3+) on Increased Oxidant Status in Children With Iron-deficiency Anemia.
    Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B.
    J Pediatr Hematol Oncol. 2014 Jan;36(1):57-61. doi: 10.1097/MPH.0b013e318299c91a.

  • Early colonoscopy confers survival benefits on colon cancer patients with pre-existing iron deficiency anemia: a nationwide population-based study.
    Teng CL, et al.
    PLoS One. 2014 Jan 22;9(1):e86714

  • Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review.
    Beguin Y, et al.
    Crit Rev Oncol Hematol, 2014; 89_1-15.

  • Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification.
    Durigova A, et al.
    Clin Chem Lab Med, 2013; 51 (9): 1833-1841.

  • Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Abdel Razeq H, et al.
    Drug Des Devel Ther. 2013 Aug 30;7:939-44.

  • Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia.
    Ludwig H, Müldür E, Endler G, Hübl W.
    Ann Oncol.2013 Jul;24(7):1886-92. doi: 10.1093/annonc/mdt118.

  • Prevalence and aetiology of anaemia in lymphoid malignancies.
    Ghosh J, et al.
    Natl med J India, 2013; 26 (2): 79-81.

  • The prevalence and clinical characteristics of cancer among anemia patients treated at an outpatient clinic.
    Kim SJ, et al.
    Blood res, 2013; 48 (1): 46-50.

  • Erythropoiesis-Stimulating Agent (ESA) Practice Patterns in Patients With Chemotherapy-Induced Anemia (CIA) Treated at Hospital Oncology Clinics.
    Reitan JF, van Breda A, Shreay S, Corey-Lisle PK, Cong Z.
    Hosp Pharm. 2013 Feb;48(2):120-6. doi: 10.1310/hpj4802-120.test.

  • Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials.
    Gafter-Gvili A, Rozen-Zvi B, Vidal L, Leibovici L, Vansteenkiste J, Gafter U, Shpilberg O.
    Acta Oncol.2013 Jan;52(1):18-29. doi: 10.3109/0284186X.2012.702921.

Deje su comentario:
Entre en su área de usuario para comentar.
No hay comentarios.